Abiomed has acquired preCARDIA, a developer of a controller catheter for patients with acute decompensated heart failure. The company's device has received Breakthrough Device Designation status from the FDA, but it is not yet available for use outside of clinical trials. Abiomed will provide a timeline for commercialization at a later date.